Clinical Trials
3 trialsNCT01696968 2026-04-30
Screening for Lung Cancer in Older Patients (PLCO Screening Trial)
National Cancer Institute (NCI)
Phase NA Active not recruiting
NCT03831932 2026-04-13
Telaglenastat Hydrochloride and Osimertinib in Treating Patients With EGFR-Mutated Stage IV Non-small Cell Lung Cancer
National Cancer Institute (NCI)
Phase 1/2 Active not recruiting
NCT01982123 2018-12-13
SPECT/CT in Measuring Lung Function in Patients With Cancer Undergoing Radiation Therapy
University of Washington
Phase NA Completed